HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recurrent and refractory giant cell tumor of the jaw.

Abstract
Recurrent giant cell tumors refractory to various treatment modalities are challenging dilemmas for the most experienced practitioner. We report a case of a multiply recurrent aggressive giant cell tumor diagnosed at 10 months of age with extensive involvement of the maxillae and mandibles unresponsive to multiple therapeutic modalities. The various treatments attempted in this patient including conventional therapies as well as the original use of bevacizumab (Avastin) are described.
AuthorsMillicent O Rovelo, Regina Kim, Leo Mascarenhas, Jeffrey Hammoudeh, Mark M Urata
JournalThe Journal of craniofacial surgery (J Craniofac Surg) Vol. 20 Issue 6 Pg. 2245-8 (Nov 2009) ISSN: 1536-3732 [Electronic] United States
PMID19934683 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Diphosphonates
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Bevacizumab
Topics
  • Angiogenesis Inhibitors (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents (therapeutic use)
  • Bevacizumab
  • Diphosphonates
  • Dwarfism (complications)
  • Embolization, Therapeutic
  • Female
  • Giant Cell Tumors (complications, pathology, surgery, therapy)
  • Humans
  • Infant
  • Interferon alpha-2
  • Interferon-alpha (therapeutic use)
  • Jaw Neoplasms (complications, pathology, surgery, therapy)
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local
  • Palliative Care
  • Recombinant Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: